References
- Nagata, S. and Golstein, P. (1995) "The Fos death factor", Science 267, 1449–1456.
- Ashkenazi, A. and Dixit, V.M. (1998) "Death receptors: signaling and modulation", Science 281, 1305–1308.
- Nagata, S (1999) "Fos ligand-induced apoptosis", Annu. Rev. Genet. 33, 29–55.
- Schneider, P. and Tschopp, J. (2000) "Apoptosis induced by death receptors", Phann. Acta. Hely. 74, 281–286.
- Sartorius, U, Schmitz, I and Krammer, PH. (2001) "Molecular mechanisms of death-receptor-mediated apoptosis", Chembiochem. 2, 20–29.
- Watanabe-Fukunaga, R., Brannan, CI., Copeland, N.G., Jenkins, NA. and Nagata, S. (1992) "Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis", Nature 356, 314–317.
- Takahashi, T., Tanaka, M., Brannan, CI., et al. (1994) "Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand", Cell 76, 969–976.
- Nagata, S. and Suda, T. (1995) "Fos and Fas ligand: lpr and gld mutations", Immunol. Today 16, 39–43.
- Fisher, G.H., Rosenberg, F.J., Straus, SE., et al. (1995) "Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome", Cell 81, 935–946. Rieux-Laucat, F., Le Deist, F., Hivroz, C., et al. (1995) "Mutations in Fos associated with human lymphoproliferative syndrome and autoimmunity", Science 268, 1347–1349.
- Drappa, J., Vaishnaw, AK., Sullivan, K.E., Chu, J.L. and Elkon, K.B. (1996) "Fas gene mutations in the Canale—Smith syndrome, an inherited lymphoproliferative disorder associated with auto-immunity", N. EngL J. Med. 335, 1643–1649.
- Wu, J., Wilson, J., He, J., Xiang, L., Schur, PH. and Mountz, J.D. (1996) "Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease", J. Clin. Investig. 98, 1107–1113.
- Le Deist, F., Emile, J.F., Rieux-Laucat, F., et al. (1996) "Clinical, immunological, and pathological consequences of Fas-deficient conditions", Lancet 348, 719–723.
- Nemazee, D., Guiet, C., Buerki, K. and Marshak-Rothstein, A. (1991) "B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras", J. Immunol. 147, 2536–2539.
- Sobel, ES., Kakkanaiah, V.N., Schiffenbauer, J., Reap, E.A., Cohen, EL. and Eisenberg, R.A. (1998) "Novel immunoregulatory B cell pathways revealed by lpr- + mixed chimeras", J. Immunol. 160, 1497–1503.
- Fukuyama, H., Adachi, M., Suematsu, S., et al. (1998) "Transgenic expression of Fos in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice", J. Immunol. 160,3805–3811.
- Rathmell, IC., Cooke, M.P., Ho, WY, et al. (1995) "CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4 + T cells", Nature 376, 181–184.
- Stalder, T., Hahn, S. and Erb, P. (1994) "Fas antigen is the major target molecule for CD4 + T cell-mediated cytotoxicity", J. Immunol. 152, 1127–1133.
- Ju, ST., Cui, H., Panka, D.J., Ettinger, R. and Marshak-Rothstein, A. (1994) "Participation of target Fas protein in apoptosis pathway induced by CD4 + Thl and CD8 + cytotoxic T cells", Proc. NatL Acad. Sci. USA 91, 4185–4189.
- Daniel, RT. and Krammer, PH. (1994) "Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells", J. Immunol. 152, 5624–5632.
- Watanabe, D., Suda, T. and Nagata, S. (1995) "Expression of Fos in B cells of the mouse germinal center and Fas- dependent killing of activated B cells", Int. Immunol. 7, 1949–1956.
- Rothstein, T.L., Wang, J.K., Panka, D.J., Foote, L.C., Marshak-Rothstein, A., et al. (1995) "Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells", Nature 374, 163–165.